Benefit of Apabetalone on Plasma Proteins in Renal Disease

類似資料

• Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208)
  著者:: Wasiak, Sylwia, 等
  出版事項: (2017)
• Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease
  著者:: Wasiak, Sylwia, 等
  出版事項: (2020)
• APABETALONE (RVX-208) REDUCES ACE2 PROTEIN ABUNDANCE AND PREVENTS SARS-COV-2 SPIKE PROTEIN BINDING TO HUMAN LUNG CELLS, A MOA THAT COULD ATTENUATE VIRAL ENTRY
  著者:: Fu, Li, 等
  出版事項: (2021)
• Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes
  著者:: Wasiak, Sylwia, 等
  出版事項: (2016)
• Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism
  著者:: Tsujikawa, Laura M., 等
  出版事項: (2019)